Cogstate Limited (ASX:CGS)

Market Cap	340.74M
Revenue (ttm)	80.98M
Net Income (ttm)	15.47M
Shares Out	171.22M
EPS (ttm)	0.09
PE Ratio	22.38
Forward PE	21.98
Dividend	0.02 (1.03%)
Ex-Dividend Date	Aug 27, 2025

Volume	105,408
Average Volume	298,936
Open	1.950
Previous Close	1.950
Day's Range	1.915 - 2.040
52-Week Range	0.860 - 1.990
Beta	-0.36
RSI	68.85
Earnings Date	Aug 22, 2025

About Cogstate

Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry-sponsored research. The company also designs and provides quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments. In addition, the company offers cognitive services including project management, data management, scientific consulting, statistical analysis, scales procurement, rate...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CGS

Financial Performance

In 2025, Cogstate's revenue was $53.09 million, an increase of 22.25% compared to the previous year's $43.43 million. Earnings were $10.14 million, an increase of 86.15%.

Financial numbers in USD